ROSEMARIE MCFATHER: Open Payments
NPI 1316565179 · NEWPORT NEWS, VA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$3,619 in 149 payments from 18 companies in 2025. Trend: 2023 $2,214 · 2024 $3,106 · 2025 $3,619
Food & beverage: $3,619
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 36 | $734 |
| Janssen Biotech, Inc. | 27 | $667 |
| Ardelyx, Inc. | 15 | $387 |
| Takeda Pharmaceuticals U.S.A., Inc. | 18 | $363 |
| Celltrion USA Inc. | 9 | $280 |
| Regeneron Healthcare Solutions, Inc. | 6 | $229 |
| PFIZER INC. | 9 | $180 |
| Ipsen Biopharmaceuticals, Inc | 3 | $155 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 7 | $135 |
| Lilly USA, LLC | 5 | $129 |
Products named: TREMFYA, IBSRELA, SKYRIZI, ENTYVIO, DUPIXENT, RINVOQ, VEGZELMA, ZYMFENTRA.
Industry payments across VA — which companies pay providers there.
